Healthcare

JNJ.N
PFE.N
MRK.N

BRIEF-Thrombogenics announces approval of Jetrea in Taiwan

* Jetrea (ocriplasmin) has been approved in Taiwan Source text: http://bit.ly/Z5qXX4 Further company coverage: (Gdynia Newsroom: +48 58 698 39 20; Gdynia.newsroom@thomsonreuters.com)

5:18am EDT

BRIEF-Integragen collaborates with IFCT on mir313p biomarker

* To collaborate with Intergroupe Francophone de Cancerologie Thoracique (IFCT) to explore role of mir-31-3p biomarker in advanced stage non-small cell lung cancer Source text for Eikon: Further company coverage: (Gdynia Newsroom: +48 58 698 39 20; Gdynia.newsroom@thomsonreuters.com)

5:16am EDT

UPDATE 1-German chemicals sector cuts 2014 sales forecast

* Says industrial customers spooked by Ukraine-Russia crisis

Basic Materials, 4:52am EDT

Samsung Elec says may acquire rest of Samsung Medison

SEOUL, Sept 2 - Samsung Electronics Co Ltd said on Tuesday that it is considering acquiring the shares of unlisted medical equipment maker Samsung Medison Co Ltd that it does not currently own.

Industrials, Technology, 4:15am EDT

BRIEF-Silence therapeutics COO quits

* Chief Operating Officer Annie Cheng has resigned from board with effect from today, ahead of moving back to New York early next year Source text for Eikon: Further company coverage:

4:11am EDT
Healthcare
Johnson & Johnson $103.73 +0.76%
Pfizer Inc $29.39 +0.03%
Merck & Co Inc $60.11 +0.18%

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.